Real-World Effectiveness and Safety of Anti-CGRP Monoclonal Antibodies in the Prevention of High-Frequency Episodic and Chronic Migraine in Romania-A Multicenter Retrospective Observational Study.

Aimovig (erenumab-aooe) - Amgen

Vyepti (eptinezumab-jjmr) - Teva, Lundbeck

Emgality (galcanezumab-gnlm) - Eli Lilly, Daiichi Sankyo

Ajovy (fremanezumab-vfrm) - Teva

http://www.ncbi.nlm.nih.gov/pubmed/42792865

Adina Maria Roceanu; Albert Vamanu; Alexandra Mastaleru; Alin Ciubotaru; Bogdan Ionut Pana; Cristina Grosu; Daniel Alexa; Emilian Bogdan Ignat; Florina Antochi; Laura-Elena Cucu; Victor Constantinescu

Sep 27, 2026